Attached files
| file | filename |
|---|---|
| EX-99.3 - EX-99.3 - OPKO HEALTH, INC. | d624896dex993.htm |
| 8-K/A - 8-K/A - OPKO HEALTH, INC. | d624896d8ka.htm |
Exhibit 23.1
November 5, 2013
OPKO Health, Inc.
4400 Biscayne Blvd.
Miami, FL 33137
We consent to the incorporation by reference in the following Registration Statements:
| 1. | Registration Statement on Form S-1 (No. 333-177962) of OPKO Health, Inc. and subsidiaries, |
| 2. | Registration Statement on Form S-3 (No. 333-172168) of OPKO Health, Inc. and subsidiaries, |
| 3. | Registration Statement on Form S-8 (No. 333-144040) of OPKO Health, Inc. and subsidiaries; |
| 4. | Registration Statement on Form S-3 (No. 333-189369) of OPKO Health, Inc. and subsidiaries, |
| 5. | Registration Statement on Form S-4 (No. 333-189640) of OPKO Health, Inc. and subsidiaries, |
| 6. | Registration Statement on Form S-3 (No. 333-190360) of OPKO Health, Inc. and subsidiaries, |
| 7. | Registration Statement on Form S-8 (No. 333-190899) of OPKO Health, Inc. and subsidiaries; and |
| 8. | Registration Statement on Form S-8 (No. 333-190900) of OPKO Health, Inc. and subsidiaries; |
of our reports dated March 12, 2013, with respect to the consolidated financial statements and internal controls of Prolor Biotech Inc. included in this Form 8-K/A of OPKO Health, Inc.
/s/ Yarel + Partners
Certified Public Accountants
Tel Aviv, Israel
November 5, 2013